• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Enoxaparin decreases serum MCP-1 concentration during haemodialysis-preliminary report.

作者信息

Rydzewska-Rosołowska Alicja, Borawski Jacek, Myśliwiec Michał

机构信息

Department of Nephrology and Transplantation with Dialysis Unit Medical University of Białystok Żurawia 14, 15-540 Białystok Poland E-mail:

出版信息

NDT Plus. 2009 Oct;2(5):429-30. doi: 10.1093/ndtplus/sfp060.

DOI:10.1093/ndtplus/sfp060
PMID:25949368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4421400/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ba/4421400/ad2ac9c57759/sfp060fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ba/4421400/ad2ac9c57759/sfp060fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ba/4421400/ad2ac9c57759/sfp060fig1.jpg

相似文献

1
Enoxaparin decreases serum MCP-1 concentration during haemodialysis-preliminary report.依诺肝素在血液透析期间可降低血清MCP-1浓度——初步报告
NDT Plus. 2009 Oct;2(5):429-30. doi: 10.1093/ndtplus/sfp060.
2
Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis.在接受血液透析的患者中，依诺肝素与普通肝素相比对血小板反应性的抑制作用。
Nephrol Dial Transplant. 2004 Jun;19(6):1559-63. doi: 10.1093/ndt/gfh209. Epub 2004 Mar 19.
3
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis.低分子量肝素依诺肝素在血液透析中作为抗凝剂静脉推注给药后48小时内的药代动力学。
Nephrol Dial Transplant. 2003 Nov;18(11):2348-53. doi: 10.1093/ndt/gfg396.
4
Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis in vitro.体外血液透析时，阿司匹林与依诺肝素合用可降低凝血。
Nephrol Dial Transplant. 2019 Mar 1;34(3):509-515. doi: 10.1093/ndt/gfy229.
5
[Enoxaparin in haemodialysis].
Pol Merkur Lekarski. 2002 Nov;13(77):433-6.
6
Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: A randomized cross-over trial.低分子量肝素依诺肝素经动脉管路与静脉管路给药用于预防血液透析或血液滤过患者体外血液循环中血栓形成的随机交叉试验
Nephrology (Carlton). 2016 Aug;21(8):663-8. doi: 10.1111/nep.12681.
7
Low molecular weight heparin for anticoagulation during haemodialysis in children--a preliminary study.低分子量肝素用于儿童血液透析期间的抗凝——一项初步研究。
Eur J Pediatr. 1996 Jan;155(1):70. doi: 10.1007/BF02115637.
8
Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.使用肝素涂层聚丙烯腈膜进行血液透析时的最佳抗凝策略。
Nephrol Dial Transplant. 2003 Oct;18(10):2097-104. doi: 10.1093/ndt/gfg272.
9
Three monocyte-related determinants of atherosclerosis in haemodialysis.血液透析中动脉粥样硬化的三个单核细胞相关决定因素。
Nephrol Dial Transplant. 2000 Sep;15(9):1414-9. doi: 10.1093/ndt/15.9.1414.
10
Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.依诺肝素与普通肝素对血液透析期间外源性血液凝固的不同影响：一项前瞻性研究。
Nephrol Dial Transplant. 2003 Jul;18(7):1376-82. doi: 10.1093/ndt/gfg058.

引用本文的文献

1
Unexpected and striking effect of heparin-free dialysis on cytokine release.无肝素透析对细胞因子释放的意外显著影响。
Int Urol Nephrol. 2017 Aug;49(8):1447-1452. doi: 10.1007/s11255-017-1589-8. Epub 2017 Apr 19.

本文引用的文献

1
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.单核细胞趋化蛋白-1/CCL2：糖尿病肾病进展性肾损伤的新型诊断标志物及治疗靶点
Am J Physiol Renal Physiol. 2008 Apr;294(4):F697-701. doi: 10.1152/ajprenal.00016.2008. Epub 2008 Feb 13.
2
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.MCP-1/CCL2作为心肌梗死和缺血性心肌病的治疗靶点。
Inflamm Allergy Drug Targets. 2007 Jun;6(2):101-7. doi: 10.2174/187152807780832265.
3
Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes.
Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):239-44. doi: 10.1080/13813450601094672.
4
Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.终末期肾病患者的肾功能损害和透析治疗时间与氧化应激和促动脉粥样硬化细胞因子水平相关。
Clin Biochem. 2007 Jan;40(1-2):81-5. doi: 10.1016/j.clinbiochem.2006.09.001. Epub 2006 Sep 14.
5
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.普通肝素、低分子量肝素和五糖：作用的基本机制、药理学及临床应用。
Hematol Oncol Clin North Am. 2005 Feb;19(1):1-51, v. doi: 10.1016/j.hoc.2004.09.003.
6
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.单核细胞趋化蛋白-1在患有心血管疾病的血液透析患者中的潜在新作用。
Am J Nephrol. 2004 Nov-Dec;24(6):635-40. doi: 10.1159/000082936. Epub 2004 Dec 22.
7
Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin.血液透析期间肝细胞生长因子/激活素A/卵泡抑素系统的激活：肝素的作用
Kidney Int. 2003 Dec;64(6):2229-37. doi: 10.1046/j.1523-1755.2003.00307.x.
8
Three monocyte-related determinants of atherosclerosis in haemodialysis.血液透析中动脉粥样硬化的三个单核细胞相关决定因素。
Nephrol Dial Transplant. 2000 Sep;15(9):1414-9. doi: 10.1093/ndt/15.9.1414.
9
Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation.内皮细胞产生单核细胞趋化蛋白-1：肝素的调节作用及其对单核细胞活化的影响
Immunology. 1997 Dec;92(4):512-8. doi: 10.1046/j.1365-2567.1997.00385.x.
10
In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure.慢性肾功能衰竭患者体内单核细胞趋化激活因子的诱导作用
Nephrol Dial Transplant. 1995 Dec;10(12):2244-9. doi: 10.1093/ndt/10.12.2244.